Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Current Opinion in Allergy and Clinical Immunology|November 9, 2018
Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthmaAlbert Y Wu, Sanjiv Sur, J Andrew Grant, et al.Current Opinion in Allergy and Clinical Immunology|December 1, 2017
Role of epigenetics and DNA-damage in asthmaAdil S Zahiruddin, J Andrew Grant, Sanjiv SurCurrent Opinion in Allergy and Clinical Immunology|April 20, 2004
Immunomodulation: the future of allergy and asthma treatmentR Matthew Bloebaum, J Andrew Grant, Sanjiv SurBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 22, 2003
Interleukin-12: potential role in asthma therapyPatricia Leonard, Sanjiv SurThe Medical Clinics of North America|November 14, 2002
Asthma: future directionsPatricia Leonard, Sanjiv SurClinical and Molecular Allergy : CMA|January 21, 2011
Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumabMichael C Saavedra, Sanjiv SurCurrent Opinion in Allergy and Clinical Immunology|December 2, 2016
IgE and eosinophils as therapeutic targets in asthmaTanvi R Patel, Sanjiv SurThe Journal of Allergy and Clinical Immunology|July 7, 2020
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspectiveKoa Hosoki, Abhijit Chakraborty, Sanjiv SurCurrent Opinion in Allergy and Clinical Immunology|December 30, 2014
Innate responses to pollen allergensKoa Hosoki, Istvan Boldogh, Sanjiv SurAdvances in Experimental Medicine and Biology|October 29, 2013
Inhaled environmental allergens and toxicants as determinants of the asthma phenotypeKristin Sokol, Sanjiv Sur, Bill T AmeredesPageof 16